[Clinical evaluation of combination therapy with Fortimicin and Cefotax in the treatment of complicated urinary tract infections]. 1987

S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
Department of Urology, School of Medicine, Hokkaido University.

Clinical efficacy of combination therapy using Fortimicin (ASTM) and Cefotax (CTX) was studied in 63 patients with complicated urinary tract infections. The patients received 200 mg of ASTM i.m. and 1 g of CTX i.v. twice a day. The overall clinical efficacy of the treatment was evaluated by criteria proposed by the Japanese UTI Committee. The overall clinical efficacy rate was 68.3%. The rate was 67.3% in the patients with single bacterial infection and 72.7% in those with mixed infections. Subjective side effects were observed in one of the patients. Drug related aggravation in laboratory tests was observed in 8 items in 8 patients, but these were mild changes. We concluded that combination therapy with ASTM and CTX was useful for the treatment of complicated urinary tract infections.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
October 1984, Hinyokika kiyo. Acta urologica Japonica,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
August 1983, The Japanese journal of antibiotics,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
May 1986, The Journal of antimicrobial chemotherapy,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
December 1989, Hinyokika kiyo. Acta urologica Japonica,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
September 1987, Hinyokika kiyo. Acta urologica Japonica,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
September 1987, Hinyokika kiyo. Acta urologica Japonica,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
January 1991, Wiener medizinische Wochenschrift (1946),
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
January 1979, Arzneimittel-Forschung,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
January 1987, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
S Sakashita, and Y Asano, and M Togashi, and A Maru, and T Koyanagi, and T Kasai, and T Namiji, and K Mitsuhashi, and I Amino, and T Kaneta
October 2017, Drugs of today (Barcelona, Spain : 1998),
Copied contents to your clipboard!